Efficacy and Safety of Interferon Alpha 2A and Pegylated Interferon Alpha 2A in Inflammatory Macular Edema

References

• Lardenoye CWTA, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113:1446–1449. doi:10.1016/j.ophtha.2006.04.029.
   PubMed Web of Science ®Google Scholar
• Durrani OM, Tehrani NN, Marr JE, et al. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88:1159–1162.
   PubMed Web of Science ®Google Scholar
• Rothova A. Inflammatory cystoid macular edema. Curr Opin Ophthalmol. 2007;18:487–492. doi:10.1097/ICU.0b-013e3282f03d2e.
   PubMed Web of Science ®Google Scholar
• Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957;147:258–267.
   PubMed Web of Science ®Google Scholar
• Abbas AK, Litchman AH. Les bases de l’immunologie fondamentale et cliniques. Elsevier. 2008:21–39.
   Google Scholar
• Gillies MC, Interferon-Alpha ST. 2b enhances barrier function of bovine retinal microvascular endothelium in vitro. Microvasc Res. 1995;49:277–288. doi:10.1006/mvre.1995.1024.
   PubMed Web of Science ®Google Scholar
• Plskova J, Greiner K, Forrester JV. Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis. Am J Ophthalmol. 2007;144:55–61. doi:10.1016/j.ajo.2007.03.050.
   PubMed Web of Science ®Google Scholar
• Bodaghi B, Gendron G, Wechsler B, et al. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol. 2007;91:335–339. doi:10.1136/bjo.2006.101550.
   PubMed Web of Science ®Google Scholar
• Paire V, Lebreton O, Weber M. Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment. J Fr Ophtalmol. 2010;33:152–162. doi:10.1016/j.jfo.2010.01.008.
   PubMed Web of Science ®Google Scholar
• Deuter CME, Kötter I, Günaydin I, et al. Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol. 2009;93:906–913. doi:10.1136/bjo.2008.153007.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Grover S, Fishman GA, Anderson RJ, et al. Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older. Ophthalmology. 1999;106:1780–1785. doi:10.1016/S0161-6420(99)90342-1.
   PubMed Web of Science ®Google Scholar
• Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47:1236–1240. doi:10.1167/iovs.05-0981.
   PubMed Web of Science ®Google Scholar
• Payne JF, Bruce BB, Lee LBK, Yeh S. Logarithmic transformation of spectral-domain optical coherence tomography data in uveitis-associated macular edema. Invest Ophthalmol Vis Sci. 2011;52:8939–8943. doi:10.1167/iovs.11-8193.
   PubMed Web of Science ®Google Scholar
• Lobo C. Pseudophakic cystoid macular edema. Ophthalmologica. 2012;227:61–67. doi:10.1159/000331277.
   PubMed Web of Science ®Google Scholar
• Stübiger N, Kötter I, Deuter C, et al. [Behçet’s disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients]. Klin Monbl Augenheilkd. 2001;218:768–773. doi:10.1055/s-2001-14920.
   PubMed Web of Science ®Google Scholar
• Alpsoy E, Durusoy C, Yilmaz E, et al. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study. Arch Dermatol. 2002;138:467–471.
   PubMed Web of Science ®Google Scholar
• Kötter I, Zierhut M, Eckstein A, et al. Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet’s disease with sight-threatening retinal vasculitis. Adv Exp Med Biol. 2003;528:521–523.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Güney-Tefekli E, Urgancioglu M. Results of interferon-alfa therapy in patients with Behçet uveitis. Graefes Arch Clin Exp Ophthalmol. 2006;244:1692–1695. doi:10.1007/s00417-006-0346-y.
   PubMed Web of Science ®Google Scholar
• Guillaume-Czitrom S, Berger C, Pajot C, Slinn J, McHugh N. Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet’s disease. Rheumatology (Oxford). 2007;46:1570–1573. doi:10.1093/rheumatology/kem045.
   PubMed Web of Science ®Google Scholar
• Gueudry J, Wechsler B, Terrada C, et al. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Am J Ophthalmol. 2008;146:837–844.e1. doi:10.1016/j.ajo.2008.08.038.
   PubMed Web of Science ®Google Scholar
• Krause L, Altenburg A, Pleyer U, Wiseman J. Longterm visual prognosis of patients with ocular Adamantiades-Behçet’s disease treated with interferon-alpha-2a. J Rheumatol. 2008;35:896–903.
   PubMed Web of Science ®Google Scholar
• Onal S, Kazokoglu H, Koc A, et al. Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis. Arch Ophthalmol. 2011;129:288–294. doi:10.1001/archophthalmol.2011.3.
   PubMed Web of Science ®Google Scholar
• Becker MD, Heiligenhaus A, Hudde T, et al. as a treatment for uveitis associated with multiple sclerosis. Br J Ophthalmol. 2005;89(10):1254–1257. doi:10.1136/bjo.2004.059121.
   PubMed Web of Science ®Google Scholar
• Malik NN, Sheth HG, Ackerman N, Davies N, Mitchell SM. A prospective study of change in visual function in patients treated with pegylated interferon alpha for hepatitis C in the UK. Br J Ophthalmol. 2008;92:256–258. doi:10.1136/bjo.2006.106278.
   PubMed Web of Science ®Google Scholar
• Maravic M. Economic impact of rheumatoid arthritis (RA) biotherapies in France. Joint Bone Spine. 2010 Jul;77(4):319–324. doi:10.1016/j.jbspin.2010.04.001.
   PubMed Web of Science ®Google Scholar
• Qian Z, Fardeau C, Cardoso JN, Jellab B, Fan X, LeHoang P. Effect of interferon α2a in cystoid macular edema due to intraocular infection. Eur J Ophthalmol. 2015 Sep-Oct;25(5):431–436. doi:10.5301/ejo.5000591.
   PubMed Web of Science ®Google Scholar
• Oray M, Onal S, Uludag G, Akbay AK, Tugal-Tutkun I. Interferon alpha for the treatment of cystoid macular edema associated with presumed ocular tuberculosis. J Ocul Pharmacol Ther. May 2017;33(4):304–312.
   PubMed Web of Science ®Google Scholar
• Invernizzi A, Iannaccone F, Marchi S, Mastrofilippo V, Coassin M, Fontana L, Salvarani C, McCluskey P, Cimino L. Interferon alpha-2a for the treatment of post-infectious uveitis secondary to presumed intraocular tuberculosis. Ocul Immunol Inflamm. 2019;27(4):643–650. doi:10.1080/09273948.2018.1431292.
   Web of Science ®Google Scholar